BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mazzoccoli L, Cadoso SH, Amarante GW, de Souza MV, Domingues R, Machado MA, de Almeida MV, Teixeira HC. Novel thalidomide analogues from diamines inhibit pro-inflammatory cytokine production and CD80 expression while enhancing IL-10. Biomedicine & Pharmacotherapy 2012;66:323-9. [DOI: 10.1016/j.biopha.2012.05.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 El-zahabi MA, Sakr H, El-adl K, Zayed M, Abdelraheem AS, Eissa SI, Elkady H, Eissa IH. Design, synthesis, and biological evaluation of new challenging thalidomide analogs as potential anticancer immunomodulatory agents. Bioorganic Chemistry 2020;104:104218. [DOI: 10.1016/j.bioorg.2020.104218] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
2 Tavallaei O, Heidarian M, Marzbany M, Aliabadi A. Cytotoxicity and pro-apoptosis activity of synthetic 1,3-thiazole incorporated phthalimide derivatives on cancer cells. Iran J Basic Med Sci 2021;24:604-14. [PMID: 34249261 DOI: 10.22038/ijbms.2021.53845.12103] [Reference Citation Analysis]
3 Viswanathan P, Gupta P, Kapoor S, Gupta S. Thalidomide promotes transplanted cell engraftment in the rat liver by modulating inflammation and endothelial integrity. J Hepatol 2016;65:1171-8. [PMID: 27422749 DOI: 10.1016/j.jhep.2016.07.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
4 Godin AM, Araújo DP, Menezes RR, de Brito AMS, Melo ISF, Coura GME, Bastos LFS, Amaral FA, Teixeira MM, de Fátima Â, Coelho MM, Machado RR. 2-Phthalimidethanol and 2-phthalimidethyl nitrate inhibit mechanical allodynia, neutrophil recruitment and cytokine and chemokine production in a murine model of articular inflammation. Pharmacol Rep 2017;69:691-5. [PMID: 28550800 DOI: 10.1016/j.pharep.2017.01.033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
5 Benjamin E, Hijji YM. A Novel Green Synthesis of Thalidomide and Analogs. Journal of Chemistry 2017;2017:1-6. [DOI: 10.1155/2017/6436185] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
6 Godin AM, Araújo DP, César IC, Menezes RR, Brito AM, Melo IS, Coura GM, Bastos LF, Almeida MO, Byrro RM, Matsui TC, Batista CR, Pianetti GA, de Fátima Â, Machado RR, Coelho MM. Activities of 2-phthalimidethyl nitrate and 2-phthalimidethanol in the models of nociceptive response and edema induced by formaldehyde in mice and preliminary investigation of the underlying mechanisms. Eur J Pharmacol 2015;756:59-66. [PMID: 25794846 DOI: 10.1016/j.ejphar.2015.02.052] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
7 Chang X, Zhu Y, Shi C, Stewart AK. Mechanism of immunomodulatory drugs' action in the treatment of multiple myeloma. Acta Biochim Biophys Sin (Shanghai) 2014;46:240-53. [PMID: 24374776 DOI: 10.1093/abbs/gmt142] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
8 Ali I, Wani WA, Haque A, Saleem K. Glutamic acid and its derivatives: candidates for rational design of anticancer drugs. Future Med Chem. 2013;5:961-978. [PMID: 23682571 DOI: 10.4155/fmc.13.62] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
9 He P, Cheng X, Staufenbiel M, Li R, Shen Y. Long-term treatment of thalidomide ameliorates amyloid-like pathology through inhibition of β-secretase in a mouse model of Alzheimer's disease. PLoS One 2013;8:e55091. [PMID: 23405115 DOI: 10.1371/journal.pone.0055091] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
10 Ferreira PMP, Costa PMD, Costa ADM, Lima DJB, Drumond RR, Silva JDN, Moreira DRDM, Oliveira Filho GBD, Ferreira JM, Queiroz MGRD, Leite ACL, Pessoa C. Cytotoxic and toxicological effects of phthalimide derivatives on tumor and normal murine cells. An Acad Bras Ciênc 2015;87:313-30. [DOI: 10.1590/0001-3765201520130345] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
11 Reis EF, Castro SB, Alves CCS, Oliveira EE, Corrêa TA, Almeida MV, Ferreira AP. Lipophilic amino alcohols reduces carrageenan-induced paw edema and anti-OVA DTH in BALB/c mice. International Immunopharmacology 2013;17:727-32. [DOI: 10.1016/j.intimp.2013.08.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
12 Condé CASR, De Almeida MV, Da Silva GDS, Sodré MBPDA, Rodrigues JCF, Navarro M. Synthesis, characterization and antileishmanial activity of copper(II) and zinc(II) complexes with diamine ligands. Transit Met Chem. [DOI: 10.1007/s11243-022-00495-7] [Reference Citation Analysis]
13 Scavone C, Brusco S, Bertini M, Sportiello L, Rafaniello C, Zoccoli A, Berrino L, Racagni G, Rossi F, Capuano A. Current pharmacological treatments for COVID-19: What's next? Br J Pharmacol 2020;177:4813-24. [PMID: 32329520 DOI: 10.1111/bph.15072] [Cited by in Crossref: 104] [Cited by in F6Publishing: 82] [Article Influence: 52.0] [Reference Citation Analysis]
14 Godin AM, Araújo DP, Menezes RR, Brito AM, Melo IS, Coura GM, Soares DG, Bastos LF, Amaral FA, Ribeiro LS, Boff D, Santos JR, Santos DA, Teixeira MM, de Fátima Â, Machado RR, Coelho MM. Activities of 2-phthalimidethanol and 2-phthalimidethyl nitrate, phthalimide analogs devoid of the glutarimide moiety, in experimental models of inflammatory pain and edema. Pharmacol Biochem Behav 2014;122:291-8. [PMID: 24780502 DOI: 10.1016/j.pbb.2014.04.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
15 Viana MDM, de Lima AA, da Silva Neto GJ, da Silva SMA, Leite AB, Dos Santos EC, Bassi ÊJ, Campesatto EA, de Queiroz AC, Barreiro EJ, Lima LM, Alexandre-Moreira MS. LASSBio-596: a New Pre-clinical Candidate for Rheumatoid Arthritis? Inflammation 2021. [PMID: 34697722 DOI: 10.1007/s10753-021-01564-2] [Reference Citation Analysis]